BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

IDM, Inc. Announces Detailed Phase III Results For Mepact In Osteosarcoma To Be Presented At ASPHO Annual Meeting


10/19/2005 5:10:20 PM

PARIS--(BUSINESS WIRE)--May 11, 2005--IDM (Immuno-Designed Molecules), a privately held biopharmaceutical company which shareholders recently entered into an agreement to combine with Epimmune Inc. (Nasdaq:EPMN), announces that the Phase III clinical results for its Liposomal Muramyl Tripeptide Phosphatidyl Ethanolamine product (L-MTP-PE), also named Mepact(TM), will be presented and discussed in a panel symposium on May 16 in Washington, DC. Presentations will be made by Dr. Paul A. Meyers (Memorial Sloan-Kettering Cancer Center), the study's principal investigator and Dr. Eugenie S. Kleinerman (The University of Texas M. D. Anderson Cancer Center). Other panel members include Dr. Richard Gorlick (The Children's Hospital at Montefiore), Dr. Edmund A. Gehan (Lombardi Comprehensive Cancer Center at Georgetown University), and Dr. Neyssa Marina (Stanford University Medical Center). The presentations and panel discussion will take place during the Annual Meeting of the American Society of Pediatric Hematology/Oncology (ASPHO), in Washington, DC at the Renaissance Hotel on May 16 from 12:45 to 2:45 p.m.

Read at BioSpace.com

Related News

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->